Raymond James Financial Inc. lessened its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 4.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 718,720 shares of the company’s stock after selling 36,102 shares during the quarter. Raymond James Financial Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $10,709,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of BMEZ. Absolute Investment Advisers LLC raised its holdings in shares of BlackRock Health Sciences Term Trust by 112.7% in the 1st quarter. Absolute Investment Advisers LLC now owns 582,256 shares of the company’s stock valued at $8,676,000 after buying an additional 308,562 shares during the period. CF Capital LLC acquired a new position in BlackRock Health Sciences Term Trust during the 4th quarter worth $3,743,000. Tabor Asset Management LP acquired a new position in BlackRock Health Sciences Term Trust during the 1st quarter worth $3,268,000. Bank of America Corp DE grew its stake in BlackRock Health Sciences Term Trust by 10.9% during the 4th quarter. Bank of America Corp DE now owns 1,355,347 shares of the company’s stock worth $19,517,000 after purchasing an additional 132,926 shares in the last quarter. Finally, Saba Capital Management L.P. grew its stake in BlackRock Health Sciences Term Trust by 0.4% during the 4th quarter. Saba Capital Management L.P. now owns 20,750,913 shares of the company’s stock worth $298,813,000 after purchasing an additional 89,523 shares in the last quarter.
BlackRock Health Sciences Term Trust Price Performance
BMEZ opened at $14.34 on Friday. BlackRock Health Sciences Term Trust has a 12 month low of $12.58 and a 12 month high of $16.75. The business has a fifty day moving average price of $14.18 and a 200 day moving average price of $14.50.
BlackRock Health Sciences Term Trust Cuts Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- EV Stocks and How to Profit from Them
- DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?
- How to Calculate Return on Investment (ROI)
- Engines to AI: Cummins’ Surprising Growth Driver
- How to Invest in Biotech Stocks
- Smaller Industrials Names Seeing Surging Growth: Here’s Why
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.